Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

'Didn't have the skills': biotech boss retires abruptly

CSL is changing its leadership with concerns about the company's growth prospects and operations. (James Ross/AAP PHOTOS)

The leader of Australia's largest biopharmaceutical company has retired suddenly after an assessment found he did not have the skills to take the company forward.

Paul McKenzie stepped down on Tuesday as chief executive and managing director of CSL, the $89 billion company announced.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.